PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.22%
Negative net income growth while TSM stands at 6.00%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.96%
D&A growth well above TSM's 0.95%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
440.14%
Well above TSM's 37.83% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
25.11%
SBC growth of 25.11% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-118.55%
Both reduce yoy usage, with TSM at -128.02%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-88.57%
AR is negative yoy while TSM is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-207.86%
Both reduce yoy inventory, with TSM at -442.69%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
212.15%
AP growth well above TSM's 114.07%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-136.03%
Both reduce yoy usage, with TSM at -122.31%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
40.14%
Some yoy increase while TSM is negative at -26.71%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-60.38%
Both yoy CFO lines are negative, with TSM at -21.68%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-46.16%
Both yoy lines negative, with TSM at -63.14%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
18.71%
Less growth in investment purchases vs. TSM's 99.81%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-13.40%
We reduce yoy sales while TSM is 32.20%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
24.46%
We have some outflow growth while TSM is negative at -162.80%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
18.35%
We have mild expansions while TSM is negative at -60.05%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
59.77%
We repay more while TSM is negative at -414.85%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
16.60%
Issuance growth of 16.60% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.